132 related articles for article (PubMed ID: 33204638)
1. Arginine kinetics are altered in a pilot sample of adolescents and young adults with Barth syndrome.
Cade WT; Bohnert KL; Bittel AJ; Chacko SJ; Patterson BW; Pacak CA; Byrne BJ; Vernon HJ; Reeds DN
Mol Genet Metab Rep; 2020 Dec; 25():100675. PubMed ID: 33204638
[TBL] [Abstract][Full Text] [Related]
2. Substrate metabolism during basal and hyperinsulinemic conditions in adolescents and young-adults with Barth syndrome.
Cade WT; Spencer CT; Reeds DN; Waggoner AD; O'Connor R; Maisenbacher M; Crowley JR; Byrne BJ; Peterson LR
J Inherit Metab Dis; 2013 Jan; 36(1):91-101. PubMed ID: 22580961
[TBL] [Abstract][Full Text] [Related]
3. Blunted fat oxidation upon submaximal exercise is partially compensated by enhanced glucose metabolism in children, adolescents, and young adults with Barth syndrome.
Cade WT; Bohnert KL; Peterson LR; Patterson BW; Bittel AJ; Okunade AL; de Las Fuentes L; Steger-May K; Bashir A; Schweitzer GG; Chacko SK; Wanders RJ; Pacak CA; Byrne BJ; Reeds DN
J Inherit Metab Dis; 2019 May; 42(3):480-493. PubMed ID: 30924938
[TBL] [Abstract][Full Text] [Related]
4. Myocardial glucose and fatty acid metabolism is altered and associated with lower cardiac function in young adults with Barth syndrome.
Cade WT; Laforest R; Bohnert KL; Reeds DN; Bittel AJ; de Las Fuentes L; Bashir A; Woodard PK; Pacak CA; Byrne BJ; Gropler RJ; Peterson LR
J Nucl Cardiol; 2021 Aug; 28(4):1649-1659. PubMed ID: 31705425
[TBL] [Abstract][Full Text] [Related]
5. Impaired cardiac and skeletal muscle bioenergetics in children, adolescents, and young adults with Barth syndrome.
Bashir A; Bohnert KL; Reeds DN; Peterson LR; Bittel AJ; de Las Fuentes L; Pacak CA; Byrne BJ; Cade WT
Physiol Rep; 2017 Feb; 5(3):. PubMed ID: 28196853
[TBL] [Abstract][Full Text] [Related]
6. Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation.
Greenwell AA; Gopal K; Altamimi TR; Saed CT; Wang F; Tabatabaei Dakhili SA; Ho KL; Zhang L; Eaton F; Kruger J; Al Batran R; Lopaschuk GD; Oudit GY; Ussher JR
Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2255-H2269. PubMed ID: 33929899
[TBL] [Abstract][Full Text] [Related]
7. Long-chain fatty acid oxidation and respiratory complex I deficiencies distinguish Barth Syndrome from idiopathic pediatric cardiomyopathy.
Chatfield KC; Sparagna GC; Specht KS; Whitcomb LA; Omar AK; Miyamoto SD; Wolfe LM; Chicco AJ
J Inherit Metab Dis; 2022 Jan; 45(1):111-124. PubMed ID: 34821394
[TBL] [Abstract][Full Text] [Related]
8. Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide.
Sabbah HN
Heart Fail Rev; 2021 Mar; 26(2):237-253. PubMed ID: 33001359
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in Barth syndrome.
Kim AY; Vernon H; Manuel R; Almuqbil M; Hornby B
Ther Adv Rare Dis; 2022; 3():26330040221093743. PubMed ID: 37180415
[TBL] [Abstract][Full Text] [Related]
10. Development and content validity of the Barth Syndrome Symptom Assessment (BTHS-SA) for adolescents and adults.
Gwaltney C; Stokes J; Aiudi A; Mazar I; Ollis S; Love E; Shields A
Orphanet J Rare Dis; 2021 Jun; 16(1):264. PubMed ID: 34108006
[TBL] [Abstract][Full Text] [Related]
11. Myocardial disturbances of intermediary metabolism in Barth syndrome.
Greenwell AA; Tabatabaei Dakhili SA; Ussher JR
Front Cardiovasc Med; 2022; 9():981972. PubMed ID: 36035919
[TBL] [Abstract][Full Text] [Related]
12. Reduced Muscle Strength in Barth Syndrome May Be Improved by Resistance Exercise Training: A Pilot Study.
Bittel AJ; Bohnert KL; Reeds DN; Peterson LR; de Las Fuentes L; Corti M; Taylor CL; Byrne BJ; Cade WT
JIMD Rep; 2018; 41():63-72. PubMed ID: 29654548
[TBL] [Abstract][Full Text] [Related]
13. Favorable outcomes after heart transplantation in Barth syndrome.
Li Y; Godown J; Taylor CL; Dipchand AI; Bowen VM; Feingold B
J Heart Lung Transplant; 2021 Oct; 40(10):1191-1198. PubMed ID: 34330606
[TBL] [Abstract][Full Text] [Related]
14. Phospholipid abnormalities in children with Barth syndrome.
Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ
J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265
[TBL] [Abstract][Full Text] [Related]
15. Barth Syndrome Cardiomyopathy: An Update.
Pang J; Bao Y; Mitchell-Silbaugh K; Veevers J; Fang X
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456462
[TBL] [Abstract][Full Text] [Related]
16. Clinical laboratory studies in Barth Syndrome.
Vernon HJ; Sandlers Y; McClellan R; Kelley RI
Mol Genet Metab; 2014 Jun; 112(2):143-7. PubMed ID: 24751896
[TBL] [Abstract][Full Text] [Related]
17. Barth syndrome: A life-threatening disorder caused by abnormal cardiolipin remodeling.
Raja V; Reynolds CA; Greenberg ML
J Rare Dis Res Treat; 2017; 2(2):58-62. PubMed ID: 31032491
[TBL] [Abstract][Full Text] [Related]
18. Glucose Uptake and Triacylglycerol Synthesis Are Increased in Barth Syndrome Lymphoblasts.
Mejia EM; Zinko JC; Hauff KD; Xu FY; Ravandi A; Hatch GM
Lipids; 2017 Feb; 52(2):161-165. PubMed ID: 28097490
[TBL] [Abstract][Full Text] [Related]
19. Characterization of lymphoblast mitochondria from patients with Barth syndrome.
Xu Y; Sutachan JJ; Plesken H; Kelley RI; Schlame M
Lab Invest; 2005 Jun; 85(6):823-30. PubMed ID: 15806137
[TBL] [Abstract][Full Text] [Related]
20. Functional exercise capacity, strength, balance and motion reaction time in Barth syndrome.
Hornby B; McClellan R; Buckley L; Carson K; Gooding T; Vernon HJ
Orphanet J Rare Dis; 2019 Jan; 14(1):37. PubMed ID: 30744648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
